Credit Suisse Ag Axonics, Inc. Call Options Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXNX
# of Institutions
18Shares Held
5.04MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Putnam Investments LLC Boston, MA239KShares$17 Million0.02% of portfolio
-
Segantii Capital Management LTD165KShares$11.7 Million1.41% of portfolio
-
Eisler Capital (Uk) Ltd. London, X098.5KShares$6.99 Million0.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA31.8KShares$2.26 Million0.02% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...